Harvest Medicine Surpasses 15,000 Patient Milestone in under 18 Months of Operation
NAPANEE, Ontario, June 19, 2018 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSX-V:ABCN) (“ABcann”) is pleased to announce that its wholly-owned subsidiary, Harvest Medicine Inc. (“Harvest Medicine” or “HMed”), one of Canada’s fastest growing specialty medical cannabis clinics, has surpassed 15,000 active patients, reaching this significant milestone in under 18 months of operation. Harvest Medicine is poised to take its education focused model across Canada, through the opening of new locations and the launch of a purpose-built telemedicine app.
Our rapid growth is a testament to our patient-centric approach and dedication to providing exceptional care. We partner with patients to empower them to be more involved in their healthcare and ensure that they receive the safest and most effective medical cannabis treatment for their individualized needs.
Shekhar Parmar, Chief Executive Officer of HMed
With the opening of a new location in the Edmonton area planned for July, and launch of the telemedicine app expected by the end of the summer, Harvest Medicine is expecting strong continued growth.
“Our vision is to transform the medical cannabis experience for patients and physicians and be recognized as the trusted leader in medical cannabis care across the country,” said Mr. Parmar.
According to Health Canada statistics, the number of registered medical cannabis patients continues to grow dramatically across Canada. At the end of December 2017, there were 269,502 registered medical cannabis patients, a growth of over 54% since April 2017 and over 579% since December 2015.
Demonstrating its commitment to being a leader in the medical market, ABcann acquired Harvest Medicine in January 2018. The insights gained from Harvest Medicine regarding patient experiences, needs, required products and desire for greater guidance inspired ABcann to develop a specialty medical brand: Beacon Medical. Beacon will be a recognized producer of standardized pharma-grade cannabis products that HMed patients will be able to access, together with products of other Licensed Producers.
For more information about Harvest Medicine, visit hmed.ca.
About Harvest Medicine
Harvest Medicine, a wholly-owned subsidiary of ABcann Global Corporation (TSX-V:ABCN), is an education focused, patient-centric, cannabis discovery center and clinic that has received tremendous response from its patients. Growing to over 15,000 active patients in under 18 months, HMed is one of Canada’s most successful and fastest growing cannabis clinics. Harvest Medicine is poised to aggressively expand its effective and highly scalable model across the country. Using a highly trained team of medical doctors and Canna Genius educators, Harvest Medicine provides a welcoming environment that focuses on empowering and educating patients on the safe, effective use of medical cannabis. HMED.ca provides patients clear explanations of the medical cannabis process as well as additional educational resources such as strain reviews, Licensed Producer reviews, success stories, and accessory recommendations.
About ABcann:
ABcann is recognized for high-quality, trusted products and services. It holds production and sales licenses from Health Canada, and its flagship facility in Napanee, Ontario contains proprietary plant-growing technology, centred on its specially designed, environmentally-controlled growing chambers. This approach results in the production of pharmaceutical-grade cannabis products. ABcann is expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, such as Germany, Australia and Israel.
